美洲虎健康组织获得欧洲MYCA-4治疗治疗先天性腹泻病的专利。 Jaguar Health receives European patent for MYCA-4® therapy in treating Congenital Diarrheal Disorders.

美洲虎健康公司获得了一项新的欧洲专利,加强了其治疗同源性腹泻病(CDDs)的MYCA-4疗法的知识产权保护。 Jaguar Health Inc. has received a new European patent, strengthening intellectual property protection for its MYCA-4® therapy in treating Congenital Diarrheal Disorders (CDDs). 这一专利扩大了以植物为基础的处方药的覆盖范围,加强了公司在处理CDD方面先驱的地位,提供了强化的专利技术保护。 This patent broadens coverage for the plant-based prescription medicine and bolsters the company's position as a pioneer in treating CDDs, offering enhanced proprietary technology protection.